Program I position undoubtedly raises the volume of complexity for almost any exploration review. For example, all researchers—no matter if preclinical or scientific—have to get Agenda I investigation registrations. 21 CFR portion 1301.18. In contrast, researchers which have DEA Practitioner registrations in Schedules II–V (which most medical